Here is a list of principal investigators, current research projects, and funding sources:

C.M. Townsend, Jr., M.D., Studies in Gastrointestinal Endocrinology (Program Project Grant), NIH
C.M. Townsend, Jr., M.D., Surgical Studies of GI Peptides-Mechanisms of Action, NIH

Patricia E. Blakeney, Ph.D., Outpatient Social Skills Training to Amplify Positive Gains, NIDRR

Elisabet Borsheim, Ph.D., Amino Acid Alterations in Traumatic Brain Injury, Moody Endowment
Elisabet Borsheim, Ph.D., Visceral Fat Contribution to Very Low Density Lipoprotein (VLDL)-triglyceride Synthesis in Women, Center for Interdisciplinary Research in Women's Health

Dai Chung, M.D., Role of Gastrin-releasing Peptide in Neuroblastomas, NIH
Dai Chung, M.D., Role of Protein Kinase D Pathway During Oxidative Stress-induced Gut Injury in Severe Burns, Shriners Hospitals for Children

Ella Englander, Ph.D., Hypoxia-Induced DNA Damage and Repair in the Rat Brain, NIH
Ella Englander, Ph.D., Neuroprotective Role of Neuroglobin in the Developing Brain in Perinatal Hypoxia, March of Dimes
Ella Englander, Ph.D., Transgenic Neuroglobin Mouse Model of Smoke Inhalation Injury, Shriners Hospitals for Children
Ella Englander, Ph.D., Mechanisms of Neurotoxicity of Combustion Smoke Inhalation to the Brain, NIH

B. Mark Evers, M.D., Surgical Research Training in Gastrointestinal Endocrinology, NIH
B. Mark Evers, M.D., Surgical Studies of Ontogeny, Aging and the Gut, NIH
B. Mark Evers, M.D., Surgical Studies of Functional Gene Expression, NIH
B. Mark Evers, M.D., Surgical Studies of Aging and the Gut, NIH
B. Mark Evers, M.D., Surgical Studies of Signaling Pathways in GI Cancers, NIH

Guillermo A. Gomez, M.D., Comparison of surgery versus endoscopic closure of a large linear colon perforation, Ethicon Endo-Surgery, Inc.

George H. Greeley, Jr., Ph.D., Role of Apelin in IBD, Crohn's & Colitis Foundation of America
George H. Greeley, Jr., Ph.D., Modulation of Oxidative Stress in the Aging Brain, John Sealy Endowment
George H. Greeley, Jr., Ph.D., Regulation of Ghrelin and Growth Hormone during Aging, John Sealy Endowment
George H. Greeley, Jr., Ph.D., Regulation of Stomach Ghrelin, NIH

Kristene K. Gugliuzza, M.D., A One-Year, Multicenter, Partially Blinded, Double-Dummy Randomized Study to Evaluate the Efficacy and Safety of FTY720 Combined with Reduced-Dose or Full Dose Neoral and Corticosteroids Versus Mycophenolate Mofetil (MMF, CellCept) Combined with Full-Dose, Novartis Pharmaceuticals Corporation
Kristene K. Gugliuzza, M.D., Myfortic and Prograf vs. Neoral Efficacy and GI Complications, Novartis Pharmaceuticals Corporation
Kristene K. Gugliuzza, M.D., A 12-Month Open-label, Randomized, Multicenter, Sequential Cohort, Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of Oral AEB071 versus Tacrolimus in combination with myfortic®, Simulect®, and corticosteroids in de novo adult renal transplant recipients, Novartis Pharmaceuticals Corporation
Kristene K. Gugliuzza, M.D., A Prospective, Randomized, Multi-Center Double-Blind Study of Early Corticosteroid Cessation vs. Long Term Maintenance Corticosteroid Therapy with Prograf® and CellCept® in Primary Renal Transplant Recipients, Astellas Pharma US, Inc.

Mark R. Hellmich, Ph.D., Studies of a Novel CCK-B/Gastrin Receptor Splice Variant, John Sealy Endowment

David N. Herndon, M.D., Shrine Research Core, Shriners Hospitals for Children
David N. Herndon, M.D., Postdoctoral Training in Trauma and Burns, NIH
David N. Herndon, M.D., Modulation of the Postburn Hypermetabolic Response, NIH
David N. Herndon, M.D., Pediatric Burn Injury Rehabilitation Model System, NIDRR
David N. Herndon, M.D., Assess Anabolic Agents/Exercise in Burned Children, NIGMS
David N. Herndon, M.D., Inflammation and the Host Response to Injury, Massachusetts General Hospital

Lois A. Killewich, M.D., Ph.D., Phase 3, Multicenter, Multinational, Randomized, Partial Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy And Safety of Alfimeprase In Subjects With Acute Peripheral Arterial Occlusion, Nuvelo, Inc.

Kathleen L. O'Connor, Ph.D., Novel Mechanisms of Carcinoma Cell Migration, National Cancer Institute

Taylor S. Riall, M.D., Ph.D., Underutilization of Surgical Resection in Patients with Pancreatic Cancer, Society of University Surgeons
Taylor S. Riall, M.D., Ph.D., Pancreatic cancer in the elderly: Population-based outcomes following surgical resection, American Geriatrics Society

Hiroshi Saito, Ph.D., IL-15 and Adipocytokines in Sarcopenia, NIH (Pilot project)
Hiroshi Saito, Ph.D., Vulnerability to Sepsis in Old Age, NIH

Oscar E. Suman, Ph.D., Exercise and Quality of Life in Severely Burned Children, NIH
Oscar E. Suman, Ph.D., Physiological Adaptation to Exercise in Burned Children, NIH

Philip G. Thomas, M.D., Phase IV Non-Interventional, Multi-Center, Open-Label, Prospective, Observational Study of the Safety, Effectiveness & Tolerability of Immunosuppressant Regimens using Mycophenolic Acid to Treat de novo Renal Transplant Patients in Routine Clinical Practice, Novartis Pharmaceuticals Corporation

Xiaojun Zhang, M.D., Special Shared Facilities-Mass Spectrometry Core, Shriners Hospitals for Children